Bravi D - Search Results

1

Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.

Stocchi F, Ruggieri S, Antonini A, Baronti F, Brughitta G, Bellantuono P, Bravi D, Agnoli A. Stocchi F, et al. Among authors: bravi d. J Neural Transm Suppl. 1988;27:27-33. doi: 10.1007/978-3-7091-8954-2_4. J Neural Transm Suppl. 1988. PMID: 3165437

2

Comparison between L-dopa and lisuride intravenous infusions: a clinical study.

Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A. Ruggieri S, et al. Among authors: bravi d. Mov Disord. 1988;3(4):313-9. doi: 10.1002/mds.870030405. Mov Disord. 1988. PMID: 3211176

3

A pharmacological study of dopaminergic receptors in planaria.

Venturini G, Stocchi F, Margotta V, Ruggieri S, Bravi D, Bellantuono P, Palladini G. Venturini G, et al. Among authors: bravi d. Neuropharmacology. 1989 Dec;28(12):1377-82. doi: 10.1016/0028-3908(89)90013-0. Neuropharmacology. 1989. PMID: 2559350

4

[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].

Stocchi F, Ruggieri S, Baronti F, Bellantuono P, Brughita G, Antonini A, Bravi D, Agnoli A. Stocchi F, et al. Among authors: bravi d. Clin Ter. 1987 Jul 31;122(2):83-8. Clin Ter. 1987. PMID: 2973904 Italian. No abstract available.

5

Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar).

Torti M, Alessandroni J, Bravi D, Casali M, Grassini P, Fossati C, Ialongo C, Onofrj M, Radicati FG, Vacca L, Bonassi S, Stocchi F. Torti M, et al. Among authors: bravi d. Br J Clin Pharmacol. 2019 Nov;85(11):2605-2613. doi: 10.1111/bcp.14086. Epub 2019 Sep 12. Br J Clin Pharmacol. 2019. PMID: 31378952 Free PMC article. Clinical Trial.

6

Are All Dopamine Agonists Essentially the Same?

Torti M, Bravi D, Vacca L, Stocchi F. Torti M, et al. Among authors: bravi d. Drugs. 2019 May;79(7):693-703. doi: 10.1007/s40265-019-01103-2. Drugs. 2019. PMID: 30968290 Review.

7

Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot study.

Vacca L, Proietti S, Bravi D, Radicati FG, Stocchi F. Vacca L, et al. Among authors: bravi d. Neurol Sci. 2022 Feb;43(2):1055-1059. doi: 10.1007/s10072-021-05342-8. Epub 2021 Jun 4. Neurol Sci. 2022. PMID: 34086122

8

No evidence for altered muscle mitochondrial function in Parkinson's disease.

Anderson JJ, Bravi D, Ferrari R, Davis TL, Baronti F, Chase TN, Dagani F. Anderson JJ, et al. Among authors: bravi d. J Neurol Neurosurg Psychiatry. 1993 May;56(5):477-80. doi: 10.1136/jnnp.56.5.477. J Neurol Neurosurg Psychiatry. 1993. PMID: 8505638 Free PMC article.

9

Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trials.

Antonini A, Bravi D, Sandre M, Bubacco L. Antonini A, et al. Among authors: bravi d. Expert Opin Investig Drugs. 2020 Jul;29(7):685-695. doi: 10.1080/13543784.2020.1771693. Epub 2020 Jun 12. Expert Opin Investig Drugs. 2020. PMID: 32419521 Review.

10

Disease progression in Parkinson subtypes: the PPMI dataset.

Aleksovski D, Miljkovic D, Bravi D, Antonini A. Aleksovski D, et al. Among authors: bravi d. Neurol Sci. 2018 Nov;39(11):1971-1976. doi: 10.1007/s10072-018-3522-z. Epub 2018 Aug 14. Neurol Sci. 2018. PMID: 30109466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters